TABLE 1

Schematics of Imaging and Therapy Regimen

Group	n	Day 0	Day 1	Day 2	Day 3
¹⁸F-alfatide II imaging (40 vs. 60 min) (U87MG, 7 mice; MDA-MB-435, 8 mice)
1	15		^*
¹⁸F-FDG signal recovery validation (U87MG, 6 mice; MDA-MB-435, 8 mice)
2	15		^†	^‡
Therapy monitoring, U87MG
3
Control	4	^‡			^‡
Treated	5	^‡^§		^§	^‡
Therapy monitoring, MDA-MB-435
4
Control	6	^‡			^‡
Treated	8	^‡^∥		^∥	^‡